How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions

How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions

<br/><strong>Background: </strong>Context matters for the successful implementation of medical interventions, but its role remains surprisingly understudied. Against the backdrop of antimicrobial resistance, a global health priority, we investigated the introduction of a rapid diag...

Descripció completa

Dades bibliogràfiques
Autors principals:	Haenssgen, M, Charoenboon, N, Do, N, Althaus, T, Khine Zaw, Y, Wertheim, H, Lubell, Y
Format:	Journal article
Idioma:	English
Publicat:	BioMed Central 2019

Ítems similars

How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions
per: Marco J. Haenssgen, et al.
Publicat: (2019-02-01)

A comparison of patients’ local conceptions of illness and medicines in the context of C-reactive protein biomarker testing in Chiang Rai and Yangon
per: Khine Zaw, Y, et al.
Publicat: (2018)

It is time to give social research a voice to tackle AMR
per: Haenssgen, M, et al.
Publicat: (2018)

The social role of C-reactive protein point-of-care testing to guide antibiotic prescription in Northern Thailand
per: Haenssgen, M, et al.
Publicat: (2018)

The Consequences of AMR Education and Awareness Raising: Outputs, Outcomes, and Behavioural Impacts of an Antibiotic-Related Educational Activity in Lao PDR
per: Marco J. Haenssgen, et al.
Publicat: (2018-11-01)

Antibiotics and activity spaces: An exploratory study of behaviour, marginalisation, and knowledge diffusion [project overview]
per: Haenssgen, M, et al.
Publicat: (2018)

Precarity and clinical determinants of healthcare-seeking behaviour and antibiotic use in rural Laos and Thailand
per: Marco J Haenssgen, et al.
Publicat: (2020-12-01)

Biomarker tests for bacterial infection-a costly wait for the holy grail
per: Lubell, Y, et al.
Publicat: (2017)

Antibiotic knowledge, attitudes and practices: new insights from cross-sectional rural health behaviour surveys in low-income and middle-income South-East Asia
per: Haenssgen, M, et al.
Publicat: (2019)

Modelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical Settings
per: Lubell, Y, et al.
Publicat: (2016)

Modelling the impact and cost-effectiveness of biomarker tests as compared with pathogen-specific diagnostics in the management of undifferentiated fever in remote tropical settings
per: Lubell, Y, et al.
Publicat: (2016)

Antibiotic knowledge, attitudes and practices: new insights from cross-sectional rural health behaviour surveys in low-income and middle-income South-East Asia
per: Jeffrey Lienert, et al.
Publicat: (2019-08-01)

Antibiotics and activity spaces: protocol of an exploratory study of behaviour, marginalisation and knowledge diffusion
per: Haenssgen, M, et al.
Publicat: (2018)

A rich man’s world: biases of big data in a development context
per: Haenssgen, M
Publicat: (2017)

Point-of-care C-reactive protein testing and antibiotic prescribing
per: Althaus, T, et al.
Publicat: (2021)

Modelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical Settings.
per: Yoel Lubell, et al.
Publicat: (2016-01-01)

Satellite-aided survey sampling and implementation in low- and middle-income contexts: a low-cost/low-tech alternative.
per: Haenssgen, M
Publicat: (2015)

Can Qualitative Research Inform Policy Implementation? Evidence and Arguments from a Developing Country Context
per: Brigitte Smit
Publicat: (2003-09-01)

Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial
per: Althaus, T, et al.
Publicat: (2018)

Can Salivary Acetylcholinesterase be a Diagnostic Biomarker for Alzheimer?
per: Sedigheh Bakhtiari, et al.
Publicat: (2017-01-01)

Biomarkers for prediction and diagnostics of preeclampsia
per: O. V. Radkov, et al.
Publicat: (2018-04-01)

How can small satellites improve the health of citizens in equatorial countries and Singapore in a context of climate change?
per: Lim, Yin Qi
Publicat: (2024)

How can small satellites improve food security of equatorial countries and Singapore in a context of climate change?
per: Lim, Wen Xuan
Publicat: (2024)

How Hybridization of Energy Storage Technologies Can Provide Additional Flexibility and Competitiveness to Microgrids in the Context of Developing Countries
per: Linda Barelli, et al.
Publicat: (2019-08-01)

Diagnostic biomarker kinetics: how brain-derived biomarkers distribute through the human body, and how this affects their diagnostic significance: the case of S100B
per: Robert Murcko, et al.
Publicat: (2022-05-01)

Accounting for aetiology: can regional surveillance data alongside host biomarker-guided antibiotic therapy improve treatment of febrile illness in remote settings?
per: Chandna, A, et al.
Publicat: (2019)

Breath Biomarkers in Diagnostic Applications
per: Y Lan Pham, et al.
Publicat: (2021-09-01)

How can small satellites improve the resilience of equatorial countries and Singapore in a context of regional explosive volcanic eruption?
per: Seah, Yi Da
Publicat: (2024)

Understanding contexts: how explanatory theories can help
per: Frank Davidoff
Publicat: (2019-03-01)

Economic considerations support C-reactive protein testing alongside malaria rapid diagnostic tests to guide antimicrobial therapy for patients with febrile illness in settings with low malaria endemicity
per: Lubell, Y, et al.
Publicat: (2019)

Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries
per: Ashley, E, et al.
Publicat: (2011)

Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries.
per: Ashley, E, et al.
Publicat: (2011)

How far can biomarkers take us in neurodegenerative disorders?
per: Husain, M
Publicat: (2017)

Can the future really be predicted?
per: Htike@Muhammad Yusof, Zaw Zaw
Publicat: (2013)

How can malaria rapid diagnostic tests achieve their potential? A qualitative study of a trial at health facilities in Ghana
per: Ansah Evelyn K, et al.
Publicat: (2010-04-01)

Inter-prescriber variability in the decision to prescribe antibiotics to febrile patients attending primary care in Myanmar
per: Swe, MMM, et al.
Publicat: (2021)

FORUMS OF SCIENTIFIC AND CREATIVE INTELLIGENTSIA OF THE CIS COUNTRIES: SOCIO-CULTURAL CONTEXT
per: Y N Savichev
Publicat: (2015-12-01)

How can globalization affect inflation? Example of EMU countries
per: Milan Kostić, et al.
Publicat: (2024-12-01)

How can developing countries harness biotechnology to improve health?
per: Persad Deepa L, et al.
Publicat: (2007-12-01)

Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinomaResearch in context
per: Yang Cheng, et al.
Publicat: (2019-02-01)